Mononuclear cell frozen stock solution of cord blood, application and preparation method

A cryopreservation method and a technology for nuclear cells, which are used in applications, preservation of human or animal bodies, animal husbandry, etc., can solve problems such as affecting the therapeutic effect of cells, reducing viability, and complex components, and improving safety and viability. High, value-enhancing effects

CN104705291AInactive Publication Date: 2015-06-17GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD
2 Cites 14 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2015-06-17
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the field of biological technology, and particularly relates to a mononuclear cell frozen stock solution of cord blood, an application and a preparation method. The mononuclear cell frozen stock solution of cord blood provided by the invention comprises dimethyl sulfoxide (DMSO) united plasmalyte force A (compound electrolyte injection) and hydroxyethyl starch (HES). Compared with the traditional formula, the scheme can be used for effectively preventing the pollution of animal derived pathogens and avoiding using of a cell culture medium to serve as a component of the frozen stock solution and guaranteeing a good cell frozen stock effect; after cell frozen for 2 months, the average cell viability of resurgent CBMC cell frozen by the cell frozen solution is 94.73%, which is remarkably (P is smaller than 0.05) higher than the cell frozen effect of the traditional cell frozen solution (10%DMSO+90%FBS). The resurgent cell can be directly applied to clinical transplantation, so the mononuclear cell frozen stock solution of the cord blood has a large practical value in clinical application of cell therapy.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the field of biotechnology, in particular to a cord blood mononuclear cell cryopreservation solution, application and preparation method. Background technique

[0002] Cord blood mononuclear cell (CBMC) refers to cells with a single nucleus in cord blood, including hematopoietic stem cells, lymphocytes, monocytes, dendritic cells and a small number of other cells. CBMC can promote the body's hematopoiesis and enhance the body's immunity in vivo; it can induce differentiation into a variety of immune cells in vitro, such as cytokine-induced killer cells (CIK), natural killer cells (NK), and natural killer T cells (NKT) , has important uses in anti-tumor, anti-infection and other aspects. Therefore, cryopreservation of CBMC is of great significance in cell therapy.

[0003] Cell cryopreservation is one of the main methods for long-term preservation of cells. Using cryopreservation technology to store cells in -196°C liquid nit...

Examples

Embodiment 1

[0061] DMSO 15% (volume fraction)

[0062] Hydroxyethyl starch 40% (volume fraction)

[0063] Burmaline A balance

[0064] Mix the above components.

Embodiment 2

[0066] DMSO 10% (volume fraction)

[0067] Hydroxyethyl starch 30% (volume fraction)

[0068] Burmaline A balance

[0069] Mix the above components.

Embodiment 3

[0071] DMSO 5% (volume fraction)

[0072] Hydroxyethyl starch 60% (volume fraction)

[0073] Burmaline A balance

[0074] Mix the above components.